Anifrolumab (Saphnelo) listed in MB

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.

For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Lupus Blog Articles:

The Lupus Canada Annual General Meeting 2026

Read

Disability Benefits in Canada | Pathway to Benefits

Read

Lupus Canada Impact Report 2025 | Advocacy, Awareness & Research Outcomes

Read